NCT00599560View on ClinicalTrials.gov

Vasopressin and V2 Receptor in Meniere's Disease

NACompletedINTERVENTIONAL
Enrollment

135

Participants

Timeline

Start Date

April 30, 1998

Primary Completion Date

September 30, 2005

Study Completion Date

September 30, 2005

Conditions
Meniere Disease
Interventions
GENETIC

vasopressin, V2 receptor and cyclic AMP

plasma vasopressin, V2 receptor, cyclic AMP

Trial Locations (1)

565-0871

Department of Otolaryngology, Osaka University, School of Medicine, Suita

All Listed Sponsors
collaborator

Osaka City University

OTHER

lead

Osaka University

OTHER

NCT00599560 - Vasopressin and V2 Receptor in Meniere's Disease | Biotech Hunter | Biotech Hunter